What's New on the FDA Drugs Site
May 2, 2016
- Drug Firm Annual Registration Status (updated)
- Drug Firm Annual Registration Status Download File (updated)
- FDA approves Nuplazid (pimavanserin) tablets, the first drug to treat hallucinations and delusions associated with Parkinson’s disease
- FDA Drug Safety Communication: FDA approves brand name change for antidepressant drug Brintellix (vortioxetine) to avoid confusion with antiplatelet drug Brilinta (ticagrelor)
- FDA Drug Shortages
- Atropine Sulfate Injection (Updated - Currently in Shortage)
- Cefazolin Injection (Updated - Currently in Shortage)
- Cefotaxime Sodium (Claforan) Injection (Updated - Currently in Shortage)
- Dexamethasone Sodium Phosphate Injection (Updated - Currently in Shortage)
- Fentanyl Citrate (Sublimaze) Injection (Updated - Currently in Shortage)
- Gemifloxacin Mesylate (Factive) Tablets (Updated - Currently in Shortage)
- Penicillin G Benzathine (Bicillin L-A) Injection (Updated - Currently in Shortage)
- Sufentanil Citrate (Sufenta) Injection (Updated - Currently in Shortage)
- National Drug Code Directory
- Wholesale Distributor and Third-Party Logistics Providers Reporting (updated)
No hay comentarios:
Publicar un comentario